Begonya Nafría

754 total citations
29 papers, 342 citations indexed

About

Begonya Nafría is a scholar working on Pediatrics, Perinatology and Child Health, Speech and Hearing and General Health Professions. According to data from OpenAlex, Begonya Nafría has authored 29 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 8 papers in Speech and Hearing and 7 papers in General Health Professions. Recurrent topics in Begonya Nafría's work include Pharmaceutical studies and practices (10 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Adolescent and Pediatric Healthcare (8 papers). Begonya Nafría is often cited by papers focused on Pharmaceutical studies and practices (10 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Adolescent and Pediatric Healthcare (8 papers). Begonya Nafría collaborates with scholars based in Spain, United Kingdom and France. Begonya Nafría's co-authors include Jennifer Preston, Pamela Dicks, Ségolène Gaillard, Joana Claverol, Ify Sargeant, Laure Delbecque, Søren Skovlund, Salma Malik, Behrouz Kassaï and Katherine Deane and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Begonya Nafría

23 papers receiving 335 citations

Peers

Begonya Nafría
Bella Starling United Kingdom
Jack Nunn Australia
Anna Chorniy United States
Ann Fuller Canada
Helen M. Nichols United States
Eric J. Daza United States
Bella Starling United Kingdom
Begonya Nafría
Citations per year, relative to Begonya Nafría Begonya Nafría (= 1×) peers Bella Starling

Countries citing papers authored by Begonya Nafría

Since Specialization
Citations

This map shows the geographic impact of Begonya Nafría's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Begonya Nafría with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Begonya Nafría more than expected).

Fields of papers citing papers by Begonya Nafría

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Begonya Nafría. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Begonya Nafría. The network helps show where Begonya Nafría may publish in the future.

Co-authorship network of co-authors of Begonya Nafría

This figure shows the co-authorship network connecting the top 25 collaborators of Begonya Nafría. A scholar is included among the top collaborators of Begonya Nafría based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Begonya Nafría. Begonya Nafría is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartogh, Jaap den, Ulrike Leiss, Begonya Nafría, et al.. (2025). Transition needs and preferences identified during peer visits to three European best-practice CAYA cancer Long-Term Follow-Up care centres: An EU-CAYAS-NET project. SHILAP Revista de lepidopterología. 6. 100479–100479.
2.
Millat-Martínez, Pere, et al.. (2025). Exploring reported causes of vaccine hesitancy among European adolescents and parents: results of a citizen science project. BMC Public Health. 25(1). 1136–1136. 4 indexed citations
4.
Baird, Anne‐Marie, et al.. (2023). How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action. Health Science Reports. 6(6). e1349–e1349. 10 indexed citations
5.
Nafría, Begonya, et al.. (2023). Young patients’ involvement in a composite endpoint method development on acceptability for paediatric oral dosage forms. Research Involvement and Engagement. 9(1). 108–108.
6.
Batchelor, Hannah, Pamela Dicks, Ségolène Gaillard, et al.. (2023). Optimizing expert and patient input in pediatric trial design: Lessons learned and recommendations from a collaboration between conect4children and European Patient‐CEntric ClinicAl TRial PLatforms. Clinical and Translational Science. 16(8). 1458–1468. 2 indexed citations
7.
Preston, Jennifer, et al.. (2022). Developing a More Tailored Approach to Patient and Public Involvement with Children and Families in Pediatric Clinical Research: Lessons Learned. Therapeutic Innovation & Regulatory Science. 56(6). 948–963. 17 indexed citations
8.
Lutsar, Irja, Begonya Nafría, Stefanie Breitenstein, et al.. (2022). Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children. Clinical and Translational Science. 16(3). 478–488. 6 indexed citations
9.
Brako, Francis, Mariagiovanna Scarpa, Donato Bonifazi, et al.. (2021). Children’s Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure). Pharmaceutics. 13(5). 730–730. 43 indexed citations
10.
Turner, M., Ricardo M. Fernandes, Saskia N. de Wildt, et al.. (2021). The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children. Pharmaceutical Medicine. 35(2). 71–79. 19 indexed citations
11.
Ajanovic, Sara, Bàrbara Baró, Rosauro Varo, et al.. (2021). How Did the COVID-19 Lockdown Affect Children and Adolescent's Well-Being: Spanish Parents, Children, and Adolescents Respond. Frontiers in Public Health. 9. 746052–746052. 9 indexed citations
13.
Athanasiou, Dimitrios, et al.. (2020). Global Collaborative Social Network (Share4Rare) to Promote Citizen Science in Rare Disease Research: Platform Development Study. JMIR Formative Research. 5(3). e22695–e22695. 10 indexed citations
14.
Nafría, Begonya, et al.. (2020). El largo camino al tratamiento con biológicos del asma en pediatría. Archivos de Bronconeumología. 57(4). 249–250. 2 indexed citations
15.
Tsang, Vivian W. L., Chester J. Koh, Susan McCune, et al.. (2019). Role of Patients and Parents in Pediatric Drug Development. Therapeutic Innovation & Regulatory Science. 53(5). 601–608. 17 indexed citations
16.
Skovlund, Søren, Dawn P. Richards, Begonya Nafría, et al.. (2019). PNS249 WHAT ARE THE PRIORITY PATIENT ENGAGEMENT ACTIVITIES IN MEDICINES DEVELOPMENT? RESULTS OF A GLOBAL MULTI-STAKEHOLDER CONSULTATION. Value in Health. 22. S328–S328. 3 indexed citations
17.
Kimland, Elin, et al.. (2019). Children’s views on taking medicines and participating in clinical trials. Archives of Disease in Childhood. 104(9). 900–905. 13 indexed citations
19.
Gaillard, Ségolène, Salma Malik, Jennifer Preston, et al.. (2018). Involving children and young people in clinical research through the forum of a European Young Persons’ Advisory Group: needs and challenges. Fundamental and Clinical Pharmacology. 32(4). 357–362. 42 indexed citations
20.
Nafría, Begonya, et al.. (2017). Patient Empowerment for Healthcare Decision-Making Assessing Oncology Innovation Through Multicriteria Decision Analysis. Value in Health. 20(9). A451–A451. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026